Source: Eur Respir Rev, 27 (147) 170076; 10.1183/16000617.0076-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Giovanni Ferrara, Fabrizio Luppi, Surinder S. Birring, Stefania Cerri, Antonella Caminati, Magnus Sköld, Michael Kreuter. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions. Eur Respir Rev, 27 (147) 170076; 10.1183/16000617.0076-2017

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models Source: Eur Respir Rev 2014; 23:231-238 Year: 2014 Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches Source: Eur Respir J 2006; 28: 463-465 Year: 2006 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 A supportive care decision aid tool for idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00093-2017; 10.1183/23120541.00093-2017 Year: 2018 Integrating early palliative care for patients with idiopathic pulmonary fibrosis and their caregivers Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases Year: 2020 Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2014; 23: 3-4 Year: 2014 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies Source: Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018 Year: 2018 Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020 Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Do physicians in primary health care recognize pulmonary fibrosis? Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020 Year: 2020 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015